Bank of New York Mellon
DRTX

Bank of New York Mellon’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bank of New York Mellon’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-67,424
Closed -$855K – 4367
2014
Q3 		$855K Sell
67,424
-34
-0.1% -$508 ﹤0.01% 3384
2014
Q2 		$1.15M Buy
67,458
+7,336
+12% +$109K ﹤0.01% 3238
2014
Q1 		$810K Sell
60,122
-3,474
-5% -$45.5K ﹤0.01% 3387
2013
Q4 		$814K Buy
63,596
+15,043
+31% +$158K ﹤0.01% 3399
2013
Q3 		$439K Sell
48,553
-320
-0.7% -$2.65K ﹤0.01% 3566
2013
Q2 		$352K Buy
+48,873
New +$359K ﹤0.01% 3618

Bank of New York Mellon's DRTX Position: Q4 2014 in Review

Bank of New York Mellon sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 67,424 shares — an estimated $855K sold.

Bank of New York Mellon first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $1.15M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Bank of New York Mellon reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Bank of New York Mellon sold 67,424 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $855K.
  • Bank of New York Mellon first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Bank of New York Mellon's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $1.15M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.